Abstract
Background
Major depressive disorder (MDD) is a leading cause of disability. Real-world evidence for adjunctive acupuncture with antidepressants is limited.
Methods
We retrospectively analyzed adults with MDD, diagnosed using the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5), treated at Southwest Medical University Affiliated Hospital (China) from October 2024 to August 2025 who received pharmacotherapy alone or pharmacotherapy plus manual acupuncture. Propensity score matching (1:1) balanced baseline characteristics. Outcomes [17-item Hamilton Depression Rating Scale (HAMD-17), Hamilton Anxiety Rating Scale (HAMA), Pittsburgh Sleep Quality Index (PSQI), Short Form-36 Health Survey (SF-36)] were assessed at baseline and week 8.
Results
After matching, 100 patients were included (50 per group) with comparable baseline scores. At week 8, the combination group showed lower HAMD-17 (11.2 ± 3.3 vs 17.0 ± 4.0), lower HAMA (9.8 ± 2.9 vs 14.5 ± 3.5), lower PSQI (8.0 ± 2.2 vs 10.9 ± 2.6), and higher SF-36 (62.8 ± 9.1 vs 56.7 ± 10.2) than those of the pharmacotherapy-alone group (HAMD-17/HAMA/PSQI all P < 0.001; SF-36 P = 0.012). Response (70.0% vs 54.0%) and remission (38.0% vs 28.0%) rates were numerically higher with combination therapy, while adverse events were similar (16.0% vs 14.0%; all P > 0.05) and mild. Benefits were consistent across key subgroups.
Conclusion
In this propensity score–matched real-world cohort, adjunctive acupuncture was associated with greater improvements in depressive symptoms, anxiety, sleep quality, and health-related quality of life without increased adverse events, supporting integrative care and prospective validation.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
